SL

Sophie Lotersztajn

IN Inserm: 2 patents #10 of 235Top 5%
CN CNRS: 1 patents #3,857 of 11,908Top 35%
SA Sanofi: 1 patents #1,013 of 1,881Top 55%
SA Sanofi-Aventis: 1 patents #285 of 563Top 55%
U7 Université Paris Diderot—Paris 7: 1 patents #80 of 323Top 25%
Overall (All Time): #729,306 of 4,157,543Top 20%
7
Patents All Time

Issued Patents All Time

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
10076517 Methods and pharmaceutical compositions for the treatment of fibrosis Aïda HABIB 2018-09-18
8604060 Use of antagonists of the CBI receptor for the manufacture of a composition useful for the treatment of hepatic diseases Ariane Mallat, Pascale Grenard, Boris Julien, Jeanne V. Nhieu 2013-12-10
8575125 Selective inhibitors of CB2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders Vanessa Deveaux, Fatima Teixeira Clerc, Sylvie Manin, Ariane Mallat, Jeanne Tran-Van-Nhieu 2013-11-05
8236763 Use of antagonists of the CB1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases Ariane Mallat, Pascale Grenard, Boris Julien, Jeanne Tran Van Nhieu 2012-08-07
8084422 Method of treating insulin resistance with a selective inhibitor of CB2 receptor activity Vanessa Deveaux, Fatima Teixeira Clerc, Sylvie Manin, Ariane Mallat, Jeanne Tran-Van-Nhieu 2011-12-27
7906156 CB2 receptors blocks accumulation of human hepatic myofibroblasts: a novel antifibrogenic pathway in the liver Pascale Grenard, Boris Julien, Jeanne Tran Van Nhieu, Ariane Mallat 2011-03-15
7320805 CB2 receptors blocks accumulation of human hepatic myofibroblasts: a novel artifibrogenic pathway in the liver Pascale Grenard, Boris Julien, Jeanne Tran Van Nhieu, Ariane Mallat 2008-01-22